Cefazolin
Cefazolin for Injection, USP
Approved
Approval ID
e8bd9e95-8af5-416b-b58c-e1dbe3d052ac
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 18, 2023
Manufacturers
FDA
Qilu Pharmaceutical Co., Ltd.
DUNS: 653878256
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefazolin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67184-0560
Application NumberANDA203661
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 18, 2023
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 2 g in 1 1
Code: P380M0454Z
Classification: ACTIM
Cefazolin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67184-1001
Application NumberANDA203661
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 18, 2023
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 1 g in 1 1
Code: P380M0454Z
Classification: ACTIM